TIMOTHY MILLER: Open Payments
NPI 1659343572 · LOW MOOR, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,756 in 90 payments from 18 companies in 2025. Trend: 2023 $2,234 · 2024 $2,195 · 2025 $1,756
Food & beverage: $1,756
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $335 |
| Novo Nordisk Inc | 9 | $231 |
| Otsuka America Pharmaceutical, Inc. | 10 | $201 |
| Dexcom, Inc. | 6 | $115 |
| Amgen Inc. | 7 | $109 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $86 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $84 |
| Abbott Laboratories | 4 | $81 |
| Lundbeck LLC | 4 | $79 |
| Axsome Therapeutics, Inc. | 4 | $74 |
Products named: REXULTI, AIRSUPRA, Ozempic, BREZTRI, Dexcom G6 Transmitter, OTEZLA, Kerendia, XIFAXAN.
Industry payments across VA — which companies pay providers there.
